Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Peptide epitopes of apolipoprotein B
Method for managing tax return information
Compositions and methods for the production of S-adenosylmethionine within the body
Photosensitive drum unit, assembling method therefor, and disassembling method therefor
Safety razor
Vertical non-volatile memory device
Method and apparatus for efficiently routing packets across disparate networks
  Randomly Featured Patents
Air bag device
Container with diffuse extended irrigation for cultivating plants
Camera having signal input/output device for control of or by another camera
Semiconductor substrate and method of fabricating semiconductor device
Method of manufacturing semiconductor device
Valve and micro fluid pump having the same
Row grabbing system
Method in creating a symbol pattern, symbol pattern obtained thereby, method and system for finding a position in such symbol pattern and computer program product for performing the method
Human hematopoietic stem cell